Pelthos Therapeutics Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Einhorn Andrew J. | — | Award / Grant | 12,000 | — | — | 12,000 | Dec 23, 2025 |
| Friedberg Ezra M | — | Sale | 2,000 | $28.14 | $56,280 | 32,001 | Nov 25, 2025 |
| Pauls Matthew | — | Option Exercise | 8,493 | — | — | 8,493 | Oct 2, 2025 |
| Friedberg Ezra M | — | C | 40,000 | $10.00 | $400,000 | 40,000 | Jul 1, 2025 |
| Francis Knuettel II | Chief Financial Officer | C | 10,000 | $10.00 | $100,000 | 10,000 | Jul 1, 2025 |
| Davis Todd C | — | C | 1,500,000 | $10.00 | $15,000,000 | 1,500,000 | Jul 1, 2025 |
| LIGAND PHARMACEUTICALS INC | — | C | 1,500,000 | $10.00 | $15,000,000 | 1,500,000 | Jul 1, 2025 |
| Malamut Richard | — | Purchase | 10,400 | $0.94 | $9,776 | 91,565 | Sep 12, 2024 |
| Francis Knuettel II | CEO, Pres., CFO, Treas & Secty | Purchase | 3,500 | $0.97 | $3,395 | 547,710 | Sep 12, 2024 |
| Francis Knuettel II | CEO, Pres., CFO, Treas & Secty | Purchase | 6,500 | $0.89 | $5,785 | 537,010 | Sep 11, 2024 |
| Francis Knuettel II | CEO, Pres., CFO Treas & Secty | Gift | 15,000 | — | — | 515,510 | Jun 28, 2024 |
| Friedberg Ezra M | — | Purchase | 16,667 | $6.00 | $100,002 | 545,721 | Feb 21, 2024 |
| Davis Todd C | — | Option Exercise | 29,167 | $4.80 | $140,002 | 29,167 | Feb 21, 2024 |
| Friedberg Ezra M | — | Option Exercise | 6,992 | $4.80 | $33,562 | 520,719 | Feb 21, 2024 |